Screening for endometrial cancer?

Cancer

Volumn 114, Issue 4, 2008, Pages 219-221

  Frable, William J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPSY TECHNIQUE; CANCER SCREENING; CURETTAGE; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EDITORIAL; ENDOMETRIUM CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; PAPANICOLAOU TEST; PIPELLE BIOPSY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; BIOPSY; CYTODIAGNOSIS; ENDOMETRIUM; ENDOMETRIUM TUMOR; INSTRUMENTATION; LABORATORY DIAGNOSIS; METHODOLOGY; NOTE; PATHOLOGY; VAGINA SMEAR;

BIOPSY; CYTODIAGNOSIS; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; SPECIMEN HANDLING; VAGINAL SMEARS;

EID: 51649091224     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23705     Document Type: Editorial

References (14)

1. Koss LG, Melamed MR. Koss' Diagnostic Cytology and Its Histopathologic Bases. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2006:445-447.
2. Thrall MJ, Kjeldahl KS, Savik K, Bulbahce HE, Pambuccian SE. Significance of benign endometrial cells in Papanicolaou tests from women age >40 years. Cancer (Cancer Cytopathol). 2005;105:207-216.
3. Robertson G. Screening for endometrial cancer. Med J Aust. 2003;178:657-659.
4. Kurman RJ, Solomon D. The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses. New York: Springer-Verlag; 1994:10-11.
5. Moriarty AT, Cibas ES. In: Solomon D, Nayar R. The Bethesda System for Reporting Cervical Cytology. 2nd ed. New York: Springer; 2003:57-65.
6. Fadare O, Ghofrani M, Chacho MS, Parkash V. The significance of benign endometrial cells in cervicovaginal smears. Adv Anat Pathol. 2005;12:274-287.
7. Asian DL, Crapanzano IP, Harshan M, Erroll M, Vakil B, Pirog EC. The Bethesda System 2001 recommendation for reporting of benign appearing endometrial cells in Pap tests of women age 40 years and older leads to unwarranted surveillance when followed without clinical qualifiers. Gynecol Oncol. 2007;107:86-93.
8. El-fakharany M, Meroueh C, Jurella S, Mazzara P Reporting endometrial cells in Papanicolaou smears of women age 40 and older: a qualifying educational note could prevent unnecessary follow-up biopsy. Acta Cytol. 2007;51:178-182.
9. Bean SM, Connolly K, Roberson J, Eltoum I, Chhieng DC. Incidence and clinical significance of morphologically benign-appearing endometrial cells in patients age 40 years or older: the impact of the 2001 Bethesda System. Cancer (Cancer Cytopathol). 2006;108:39-44.
10. Kipp BR, Medeiros F, Campion MB, et al. Direct uterine sampling with the Tao brush sampler using a liquid-based preparation method for the detection of endometrial cancer and atypical hyperplasia: a feasibility study. Cancer (Cancer Cytopathol). 2008;114:228-235.
11. Maksem J, Sager F, Bender R. Endometrial collection and interpretation using the Tao brush and the CytoRich fixative system: a feasibility study. Diagn Cytopathol. 1997;17:339-346.
12. Yang GC, Wan LS. Endometrial biopsy using the Tao Brush method. A study of 50 women in a general gynecologic practice. J Reprod Med. 2000;45:109-114.
13. Maksem I. Performance characteristics of the Indiana University Medical Center endometrial sampler (Tao Brush) in an outpatient office setting, first year's outcomes: recognizing histological patterns in cytology preparations of endometrial brushings. Diagn Cytopathol. 2000;22:186-195.
14. Buccoliero AM, Gheri CF, Castiglione F, et al. Liquid-based endometrial cytology: cyto-histological correlation in a population of 917 women. Cytopathology. 2007;18:241-249.